Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ixabepilone in Recurrent or Persistent Uterine Carcinosarcoma
NCT01168232Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Sep 2010
- Primary completion
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ixabepilone in uterine carcinosarcoma (UCS), sponsored by National Cancer Institute. Started Sep 2010; status: completed.
02
Drugs
ixabepilone
03
Conditions
uterine carcinosarcoma (UCS)
Beyond the preview
Go deeper on NCT01168232.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01168232.